HomeWebinarsAdvances to SYNTHIA™ Retrosynthesis Software and How They Have Accelerated Chemical Development at GlaxoSmithKline (GSK)

Advances to SYNTHIA™ Retrosynthesis Software and How They Have Accelerated Chemical Development at GlaxoSmithKline (GSK)

Webinar

Watch this webinar to learn how SYNTHIA™ retrosynthesis software has become a strategic, cutting-edge laboratory companion for organic chemists.

Ewa Gajewska, Ph.D., Chemistry Development Manager for Cheminformatics Technologies at Merck KGaA, Darmstadt, Germany, will provide you with an overview of the evolution of SYNTHIA™ retrosynthesis software, recent enhancements, and examples of benchtop validation.

John Jin Lim, Head of CASD (computer-aided synthesis design) at GSK, will describe how his team was able to shorten turnaround times for pathway discovery, route selection, and drug development considerably with the help of SYNTHIA™ retrosynthesis software.

Speakers

John Jin Lim, MS

API Chemistry
GlaxoSmithKline plc (GSK)

Senior Scientist

Ewa Gajewska, PhD

Cheminformatics Technologies
Merck KGaA, Darmstadt, Germany

Chemistry Development Manager

Webinar Information

Chemistry and synthesis

  • Reaction design and optimization
  • Duration:52 minutes

  • Language:English

  • Presented: